CVR: 41257547
DKK -14,130,000
Gross profit
Net result: DKK -92,714,000
Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC
4 more
CVR · view ownership and management
Owner registered: Sofinnova Capital X
CVR · 28/04/2026
View the full event history
Freya Biosciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,130,000 and a net result of DKK -92,714,000 compared with DKK -85,434,294 the year before. Equity in the 2025 report amounted to DKK 72,025,000.
Selskabets formål er at udvikle og drive virksomhed inden for handel med farmaceutiske produkter og udstyr samt anden i forbindelse hermed stående virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -92.7 mio. | 82.4 mio. | 72 mio. | 23 | |
| 202401/01/2024 – 31/12/2024 | - | -85.4 mio. | 141.4 mio. | 130.1 mio. | 14 | |
| 202301/01/2023 – 31/12/2023 | - | -81.1 mio. | 81.8 mio. | 75 mio. | 14 | |
| 202201/01/2022 – 31/12/2022 | - | -32.2 mio. | 16.4 mio. | -3.7 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -20.4 mio. | 32.4 mio. | 28.4 mio. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreFreya Biosciences ApS was founded on 23 March 2020.
Freya Biosciences ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
The owners of Freya Biosciences ApS include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX.
In 2025, Freya Biosciences ApS reported a gross profit of DKK -14,130,000.
The management of Freya Biosciences ApS consists of Colleen Denise Acosta.
Freya Biosciences ApS is located at Fruebjergvej 3, 2100 København Ø.
Claim this page to add your logo and social links. Free to get started.
Freya Biosciences ApS has published its annual report for 2025. Gross profit came to DKK -14,130,000, and the net result was DKK -92,714,000.
As of April 28, 2026, is registered as an owner of Freya Biosciences ApS with an ownership share of 15%.
As of December 3, 2025, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
Freya Biosciences ApS has published its annual report for 2024. Gross profit came to DKK -6,657,479, and the net result was DKK -85,434,294.
As of September 30, 2024, David Lawrence Stern has joined the board of directors of Freya Biosciences ApS.
As of September 30, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
As of September 30, 2024, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
As of September 30, 2024, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
Freya Biosciences ApS has published its annual report for 2023. Gross profit came to DKK -5,366,000, and the net result was DKK -81,096,000.
As of August 31, 2023, Randi Rich has stepped down as director of Freya Biosciences ApS.
Freya Biosciences ApS has published its annual report for 2022. Gross profit came to DKK -16,628,000, and the net result was DKK -32,157,000.
As of February 20, 2023, Claudia Maria Colciago has joined the board of directors of Freya Biosciences ApS.
As of February 20, 2023, is registered as an owner of Freya Biosciences ApS with an ownership share of 5%.
As of February 7, 2023, Randi Rich is registered as director of Freya Biosciences ApS.
Freya Biosciences ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -20,406,277.
As of July 15, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of Freya Biosciences ApS.
Freya Biosciences ApS has published its interim report for the period March 23, 2020 – December 31, 2020.
As of August 12, 2020, Henrijette Elsebeth Richter has joined the board of directors of Freya Biosciences ApS.
As of August 12, 2020, Colleen Denise Acosta has joined the board of directors of Freya Biosciences ApS.
As of August 12, 2020, Mark Smith has joined the board of directors of Freya Biosciences ApS.
As of August 12, 2020, Nicholas Haft has joined the board of directors of Freya Biosciences ApS.
As of August 12, 2020, Thomas Gundelund Rasmussen has left the board of directors of Freya Biosciences ApS.
As of August 12, 2020, Johannes Epeüs Theodoor van Hylckama Vlieg has left the board of directors of Freya Biosciences ApS.
As of March 23, 2020, Peter Finsel Bisgaard has joined the board of directors of Freya Biosciences ApS.
As of March 23, 2020, Thomas Gundelund Rasmussen has joined the board of directors of Freya Biosciences ApS.
As of March 23, 2020, Johannes Epeüs Theodoor van Hylckama Vlieg has joined the board of directors of Freya Biosciences ApS.
As of March 23, 2020, Colleen Denise Acosta is registered as adm. dir. of Freya Biosciences ApS.
Freya Biosciences ApS was founded on March 23, 2020.
Companies in the same industry and area
CVR 37812730
CVR 39315769
CVR 40169229
CVR 41372079
CVR 44931478
